Skip to Main Content
Services Talent Knowledge
Site Search
Menu

JordanKilijanski

He | Him | His

Associate

"My goal is to provide outstanding service to every client while finding practical solutions to their legal needs."

Overview

Biography

Jordan focuses his practice on corporate transactions, including mergers and acquisitions, corporate and partnership formations, and general corporate and business law. He has additional experience with open- and closed-end funds and finance.

Bar Associations

  • New York State Bar Association
Experience

Representative Experience

  • Represented an independent, not-for-profit research institute in its gift to a state university of approximately $40 million in endowed funds, tangible assets, and real estate to effectuate a combination between the research institute and university.

Prior Experience

  • Fried, Frank, Harris, Shriver & Jacobson LLP, Associate
  • Fried, Frank, Harris, Shriver & Jacobson LLP, Summer Law Clerk
  • Lipsitz Green Scime Cambria LLP, Law Clerk

Selected Honors

  • Best Lawyers: Ones to Watch® in America: Business Organizations (including LLCs and Partnerships), 2026; Corporate Law, 2025–2026; Mergers and Acquisitions Law, 2026
  • Selected to Super Lawyers Upstate New York Rising Stars: Mergers & Acquisitions, 2025
  • University at Buffalo School of Law, CALI Excellence for the Future Award: Constitutional Law, 2019
  • University at Buffalo School of Law, Order of the Coif

Featured Media

Alerts

Massachusetts Federal Court Permits Sharing Clause in Protective Order in Products Liability Case

Alerts

NYS Court of Appeals Holds That Parent May Not Recover for Emotional Injuries in Prenatal-Injury Case

Alerts

Smarter Inventory Management for Pharmacies: Navigating Online Marketplace Compliance

Alerts

Emergency Wine Run, Now Legal: New York State Opens Retail-to-Retail Sales

Alerts

California's Updated Privacy Regulations: Automated Decisionmaking Technology, Cybersecurity Audits, and Risk Assessments, Part 1

Alerts

Pharmacies on High Alert: Optum Rx's 25-Percent Therapeutic-Class Cap Creates Major Legal, Operational, and Competitive Risks